Respiratory infections with the increasing pollution have become a major cause of infectious diseases worldwide. These infectious diseases have become one of the causes of deaths in children and adults. With the growing urbanization and industrialization, pollution has also increased at an alarming rate and has led to an increase in bacterial and viral pathogens, which are the major the reasons of the respiratory infections. Respiratory diagnosis has become important with the rise of infections, also new technologies have been developed to identify the respiratory pathogens so as to control the infections timely. The growing number of infections are demanding more reliable and effective measures to curb respiratory infections. Early detection of respiratory diseases will minimize the damage caused due to secondary spread of infections.
To detect the respiratory infections, tests are performed at hospitals or diagnostic centers to evaluate the disease. Respiratory panel assays are carried out to analyze possible infections in the respiratory tract. Respiratory panel tests are conducted to detect disease and infections immediately to prevent further damage which in turn will prevent unnecessary antibiotics and reduce the unneeded cost of examination. Respiratory panel assays detect various respiratory pathogens with increased sensitivity and minimum sample handling.
Technology that has Enhanced the Productivity of Diagnostic Centers
Respiratory panel assay is a new form of technology based on multiplex PCR and molecular testing, which automatically monitors the results for the tests. Earlier, it was difficult for the physicians to diagnose the respiratory disease. However, with the advancement of the technology a new technique has been developed for diagnosis of bacterial and viral respiratory infections. The molecular technique is found to be better than the conventional PCR technique as it allows small quantities of nucleic acid to be amplified into distinguished levels. Before the introduction of respiratory panel assay the diagnoses of the infections had become a task of the physicians which in return caused resistance among various pathogens in individuals. The respiratory panel assay provides universal tool that is fit to diagnose various bacterial and viral respiratory infections. Implementation of respiratory panel assay has provided a fully functional environment to physicians that delivers excellent care, and identifies the disease in a short span of time and simultaneously reduces the cost of care and provides maximum productivity.
Respiratory Panel Assays Market Assessment by End User
Based on end users of respiratory panel assay market, the global market has been segmented into hospitals and diagnostic laboratories. Among the end users diagnostic centers as end-user segment is expected to hold the highest market share in the global market for the respiratory panel assay.
Factors Driving the Respiratory Panel Assays Market
The global market for respiratory panel assays is driven by increasing rate of toxicities and pollutants the air. These pollutants get transferred from person to person via air. According to the Center for Disease Control and Prevention (CDC) there were 25,676 laboratory-confirmed influenza cases which were treated in hospitals between October 1, 2017 and March 10, 2018. Respiratory panel assay is an easy, fast and comprehensive technique that helps in identification and diagnoses of the infection. Also, it reduces the cost of hospital and administration of unnecessary antibiotics. With the early detection of disease the patient can start with the targeted therapy required for the disease.
Regional Market Outlook
North America will continue to dominate the global market due to the availability of advanced technologies and more number of laboratory developed tests. Europe is expected to hold second large share in the global respiratory panel assays market due to growing prevalence of respiratory chronic diseases.
Examples of some of the players identified in the global organ function assays market are Accu Reference Medical Labs, Clarity Lab Solutions, LLC Majority of respiratory panel assays are available in diagnostic laboratories. However, the point-of-care organ function testing offers a global opportunity to its manufacturers, it is the common test performed globally.
Key data points covered in report
The report covers exhaustive analysis on:
By End user
The market sizing of organ function assays will be done by the adoption data triangulation approach. Demand-side approach will be followed to assess the actual market size of organ function assays. Secondary research will be used at the initial phase to identify the feasibility of the target products/technology categories and its respective segments, product and service offerings, equipment installed base in end-use facilities, adoption rate and future impact of new technologies. Additionally, per capita consumption of kits, reagents and consumables among end users will be tracked at a granular level to obtain the most accurate information. Each piece of information will be eventually analyzed during the entire research project, which will help build a strong base for the primary research information.
Primary research participants include demand-side respondents such as laboratory managers, procurement managers, research supervisors at academic and research institutes, as well as key opinion leaders in addition to supply-side respondents such as equipment and reagent manufacturers, custom solution and service providers who provide valuable insights on trends, research application of products and technologies, purchasing patterns, services offered and associated pricing.